Check out the SEC Filings of S3 for NMT today. New funding being made available by selling warrents, and getting proceeds up to $6,200,000. They also cancelled a new registration offering listed on last Friday(2/12).
New money for continuing operations and FDA application.
All above said, people putting $6 m into this suggests there is a a realistic opportunity to get some profits out! Plus they get 5 million from the warrants if the stock shootup when the results are unblinded - assuming the cash burn slows - that way they have more options while waiting for FDA approval... if
If the trials fail, company is still worth something ... if an MDT or EW is interested...